Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for PRCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 347.67M
December 31, 2025 365.87M
September 30, 2025 380.28M
June 30, 2025 385.80M
March 31, 2025 389.16M
December 31, 2024 402.22M
September 30, 2024 241.22M
June 30, 2024 251.78M
March 31, 2024 264.05M
December 31, 2023 280.75M
September 30, 2023 299.36M
Date Value
June 30, 2023 155.90M
March 31, 2023 173.13M
December 31, 2022 197.07M
September 30, 2022 220.76M
June 30, 2022 239.19M
March 31, 2022 252.75M
December 31, 2021 267.09M
September 30, 2021 283.31M
June 30, 2021 122.26M
March 31, 2021
December 31, 2020 60.96M

Shareholders' Equity Definition

Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Boston Scientific Corp. 25.86B
PAVmed, Inc. 39.52M
Abbott Laboratories 52.06B
AngioDynamics, Inc. 173.36M
Alphatec Holdings, Inc. 18.26M

Shareholders Equity (Quarterly) Related Metrics